The higher relapse rate in this subgroup is likely due to the higher proportion of HR BCP-ALL disease entities such as Ph-like and MEF2D-rearranged BCP-ALL [32–34], which are more common in adults and have a poor outcome with conventional chemotherapy [35, 36]. Here, MEF2D is linked to acute lymphoblastic leukemia.